The diagnosis and treatment of generalized anxiety disorder
- PMID: 23671484
- PMCID: PMC3651952
- DOI: 10.3238/arztebl.2013.0300
The diagnosis and treatment of generalized anxiety disorder
Abstract
Background: Generalized anxiety disorder (GAD) is a common and serious disease with a lifetime prevalence of 4.3% to 5.9%. It is underdiagnosed in primary care.
Methods: Recommendations on the treatment of GAD are given on the basis of all available findings from pertinent randomized trials, retrieved by a selective search of the literature.
Results: Among psychotherapeutic techniques, various kinds of cognitive behavioral therapy (CBT) have been found useful in controlled trials. The drugs of first choice include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephine reuptake inhibitors (SNRIs), and the calcium-channel modulator pregabalin. Tricyclic antidepressants are also effective but have more adverse effects than SSRIs. Although benzodiazepines are effective anxiolytic agents for short-term use, they should not be given over the long term because of the danger of addiction. Buspirone, an azapirone, was found to be effective in a small number of trials, but the findings across trials are inconsistent. The response rate of GAD to CBT in published studies lies between 47% and 75%, while its response rate to drug treatment lies between 44% and 81%.
Conclusion: The treatment of GAD with CBT and drugs is evidence-based and has a good chance of improving the manifestations of the disorder.
Comment in
-
Correspondence (letter to the editor): Numerous competing interests.Dtsch Arztebl Int. 2013 Sep;110(37):609. doi: 10.3238/arztebl.2013.0609a. Dtsch Arztebl Int. 2013. PMID: 24078848 Free PMC article. No abstract available.
-
Correspondence (letter to the editor): One-sided publication.Dtsch Arztebl Int. 2013 Sep;110(37):609. doi: 10.3238/arztebl.2013.0609b. Dtsch Arztebl Int. 2013. PMID: 24078849 Free PMC article. No abstract available.
-
Correspondence (letter to the editor): Regular muscle activity.Dtsch Arztebl Int. 2013 Sep;110(37):610. doi: 10.3238/arztebl.2013.0610a. Dtsch Arztebl Int. 2013. PMID: 24078850 Free PMC article. No abstract available.
-
Correspondence (letter to the editor): Professional and ethical criticism.Dtsch Arztebl Int. 2013 Sep;110(37):610. doi: 10.3238/arztebl.2013.0610b. Dtsch Arztebl Int. 2013. PMID: 24078851 Free PMC article. No abstract available.
-
Correspondence (reply): In reply.Dtsch Arztebl Int. 2013 Sep;110(37):610-1. doi: 10.3238/arztebl.2013.0610c. Dtsch Arztebl Int. 2013. PMID: 24078852 Free PMC article. No abstract available.
References
-
- Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002 63;(Suppl 8):24–34. - PubMed
-
- Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005;15:357–376. - PubMed
-
- Wittchen HU, Jacobi F, Rehm J. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655–679. - PubMed
-
- Maier W, Linden M, Sartorius N. Psychische Erkrankungen in der Allgemeinpraxis. Ergebnisse und Schlußfolgerungen einer WHO-Studie. Dtsch Arztebl. 1996;93(18):1202–1206.
-
- Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical